CIK 0000872589
- Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 133444607
- Phone
- +1 914-847-7000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- 4 Open-market sale Director sold 100 shares at an average $483.60 ($48,360)
- 4 Grant or award Director acquired 248 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and Chief Scientific gave up 216,810 shares (to pay taxes)
- 4 Grant or award EVP Research acquired 10,214 shares (grant or award)
- 4 Grant or award Director acquired 2,439 shares (grant or award)
- 4 Grant or award EVP & General Mgr Industrial O acquired 6,930 shares (grant or award)
- 4 Grant or award SVP Commercial acquired 3,075 shares (grant or award)
- 4 Grant or award EVP Research and Development acquired 1,688 shares (grant or award)
- 4 Grant or award VP Controller acquired 2,719 shares (grant or award)
- 4 Grant or award EVP Finance CFO acquired 1,930 shares (grant or award)
- 4 Grant or award EVP General Counsel and Secret acquired 1,930 shares (grant or award)
- 4 Open-market sale Director sold 100 shares at an average $520.48 ($52,048)
- 4 Open-market sale EVP Research sold 6,628 shares at an average $542.73 ($3,597,188)
- 4 Exercise or conversion Director acquired 11 shares (option exercise)
- 4 Open-market sale Director sold 100 shares at an average $548.54 ($54,854)
- 4 Exercise or conversion EVP Research acquired 5,185 shares (option exercise)
- 4 Open-market sale Director sold 9,212 shares at $600.00 ($5,527,200)
- 4 Open-market sale SVP Commercial sold 2,000 shares at an average $606.08 ($1,212,150)
Page 23 of 77 · 1,533 filings